Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 - Outcome of the Board Meeting
KANORICHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kanoria Chemicals & Industries Limited's Board of Directors met on 25th May 2026 and approved the audited standalone and consolidated financial results for Q4 and the financial year ended 31st March 2026. Statutory Auditors Singhi & Co. issued an unmodified (clean) opinion on the financial results. The Board recommended no dividend for FY 2025-26, indicating retained earnings preference. The Board also re-appointed Smt. Suhana Murshed as an Independent Director for a second 5-year term (subject to shareholder approval), and re-appointed M/s. Pawan Gupta & Co. as Internal Auditor and M/s. N. D. Birla & Co. as Cost Auditor for FY 2026-27. No specific financial numbers (revenue, PAT, EBITDA) were disclosed in this announcement.
The clean audit opinion confirms no going concern or reporting issues. The decision to skip dividend may disappoint income-focused investors but preserves cash for operations. The re-appointment of existing auditors signals continuity rather than any governance concern.